KF
GSK icon

Krilogy Financial’s GSK GSK Stock Holding History

Krilogy Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-357
Closed -$18K – 347
2018
Q3 		$18K Buy
+357
New +$18.1K ﹤0.01% 444
2018
Q2 		– Sell
-347
Closed -$17K – 348
2018
Q1 		$17K Buy
347
+5
+1% +$233 ﹤0.01% 460
2017
Q4 		$15K Sell
342
-818
-71% -$37.8K ﹤0.01% 478
2017
Q3 		$59K Buy
1,160
+662
+133% +$33.6K 0.02% 319
2017
Q2 		$27K Buy
498
+91
+22% +$4.85K 0.01% 400
2017
Q1 		$20K Hold
407
– – 0.01% 419
2016
Q4 		$20K Buy
407
+5
+1% +$247 0.01% 419
2016
Q3 		$22K Sell
402
-181
-31% -$9.92K 0.01% 427
2016
Q2 		$32K Buy
583
+269
+86% +$14.2K 0.01% 370
2016
Q1 		$16K Buy
314
+4
+1% +$199 0.01% 416
2015
Q4 		$16K Buy
310
+5
+2% +$255 0.01% 220
2015
Q3 		$15K Buy
+305
New +$15.9K 0.01% 341

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Krilogy Financial's GSK Position: Q4 2018 in Review

Krilogy Financial sold out of GSK (GSK) in Q4 2018, closing a stake of 357 shares — an estimated $18K sold.

Krilogy Financial first reported a position in GSK in Q3 2015 and held it in 12 quarters. The position peaked at $59K in Q3 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Krilogy Financial reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 357 GSK shares in Q4 2018, an estimated $18K.
  • Krilogy Financial first reported a position in GSK in Q3 2015 and held it in 12 quarters.
  • Krilogy Financial's GSK position peaked at $59K in Q3 2017.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.